Mestinon

Pyridostigmine bromide, the active ingredient in Mestinon, is an acetylcholinesterase inhibitor presented as an oral dosage form for systemic use. It improves neuromuscular transmission in conditions such as myasthenia gravis and aids recovery after surgery.

GNH USA supplies Mestinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Mestinon, an acetylcholinesterase inhibitor, is employed in several neuromuscular and postoperative conditions: - Myasthenia gravis: enhances muscle strength by increasing acetylcholine at the neuromuscular junction. - Postoperative ileus: stimulates gastrointestinal motility to promote bowel recovery after surgery. - Reversal of neuromuscular blockade: counteracts residual effects of non‑depolarizing muscle relaxants following anesthesia.

Mestinon may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: increased bowel movements. - Abdominal cramps: intermittent stomach pain. - Excessive salivation: drooling or watery mouth. - Sweating: increased perspiration. - Muscle cramps: involuntary tightening of muscles.

Serious or Rare Side Effects: - Cholinergic crisis: severe muscle weakness and respiratory difficulty. - Bradycardia: markedly slow heart rate. - Bronchospasm: narrowing of airways causing breathing trouble. - Seizures: uncontrolled electrical activity in the brain. - Anaphylaxis: life‑threatening allergic reaction. - Cardiac arrhythmias: irregular heart rhythms.

When prescribing Mestinon, clinicians should consider the following precautions: - Renal impairment: adjust dose as needed. - History of asthma or COPD: monitor for bronchospasm. - Cardiac disease: observe for bradycardia. - Concurrent anticholinergic therapy: may reduce efficacy. - Store at room temperature: keep in original container, protect from moisture.

Mestinon can interact with other medicines; notable interactions include:

Major Interactions (Avoid): - Neostigmine: additive cholinergic effects may precipitate crisis. - Beta‑blockers: can exacerbate bradycardia. - Magnesium sulfate: potentiates neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Anticholinergic agents (e.g., atropine): may diminish therapeutic effect. - Anesthetic agents such as succinylcholine: may prolong neuromuscular blockade. - Diuretics: may alter electrolyte balance affecting drug response.